The low rate of tumor development and growth precluded further in vivo analysis of the effect of CR in Atg5−/− tumors, although previous studies have established that LC3 puncta formation is negligible in Atg5−/− tumors [28]. The gene discussed is MAP1LC3A; the disease is neoplasm.